From the publisher feed

Exclusive: investigation finds prescriptions for children under 12, as experts stress need for specialist supervision and long-term monitoring Hundreds of children in England are receiving prescriptions for GLP-1 medications, including some younger than 12, the Guardian can reveal. GLP-1 medications were initially developed to help people with type 2 diabetes control their blood sugar le

Read the original at The Guardian ↗

Opens the original publisher page. Access, copyright and subscriptions are controlled by the publisher.

A useful next step

  1. Read the short publisher description here.
  2. Open the full report directly at the publisher.
  3. Compare this topic with other sources when useful.